British patients on the National Health Service will get access to two intensive arthritis therapies: MabThera, made by Roche; and Humira, made by Abbott Laboratories. Patient advocacy groups have been lobbying for the drugs since the National Institute for Health and Clinical Excellence (NICE) refused to add Orencia, a similar medication, to the NHS formulary. ReleaseÂ